Medexus Pharmaceuticals (MEDXF) Earnings Date & Reports

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MEDXF is expected to report earnings to rise 162.00% to -5 cents per share on August 06

Medexus Pharmaceuticals MEDXF Stock Earnings Reports

Q2'25

Est.

$-0.05

Q1'25

Beat

by $0.05

The last earnings report on June 25 showed earnings per share of -1 cents, beating the estimate of -6 cents. With 19.34K shares outstanding, the current market capitalization sits at 31.92M.

View a ticker or compare two or three

Compare

MEDXF